ArticleJournal of the American Medical Informatics Association : JAMIA2025
Including AI in diffusion-weighted breast MRI has potential to increase reader confidence and reduce workload.
Article in Journal of the American Medical Informatics Association : JAMIA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectivesBreast diffusion-weighted imaging (DWI) has shown potential as a standalone imaging technique for certain indications, eg, supplemental screening of women with dense breasts. This study evaluates an artificial intelligence (AI)-powered computer-aided diagnosis (CAD) system for clinical interpretation and workload reduction in breast DWI. MATERIALS AND
methodsThis retrospective IRB-approved study included: n = 824 examinations for model development (2017-2020) and n = 235 for evaluation (01/2021-06/2021). Readings were performed by three readers using either the AI-CAD or manual readings. BI-RADS-like (Breast Imaging Reporting and Data System) classification was based on DWI. Histopathology served as ground truth. The model was nnDetection-based, trained using 5-fold cross-validation and ensembling. Statistical significance was determined using McNemar's test. Inter-rater agreement was calculated using Cohen's kappa. Model performance was calculated using the area under the receiver operating curve (AUC).
resultsThe AI-augmented approach significantly reduced BI-RADS-like 3 calls in breast DWI by 29% (P =.019) and increased interrater agreement (0.57 ± 0.10 vs 0.49 ± 0.11), while preserving diagnostic accuracy. Two of the three readers detected more malignant lesions (63/69 vs 59/69 and 64/69 vs 62/69) with the AI-CAD. The AI model achieved an AUC of 0.78 (95% CI: [0.72, 0.85]; P <.001), which increased for women at screening age to 0.82 (95% CI: [0.73, 0.90]; P <.001), indicating a potential for workload reduction of 20.9% at 96% sensitivity. DISCUSSION AND
conclusionBreast DWI might benefit from AI support. In our study, AI showed potential for reduction of BI-RADS-like 3 calls and increase of inter-rater agreement. However, given the limited study size, further research is needed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.